Transmitted drug resistance in French HIV-2-infected patients

被引:12
|
作者
Charpentier, Charlotte [1 ]
Visseaux, Benoit [1 ]
Benard, Antoine [2 ]
Peytavin, Gilles [3 ]
Damond, Florence [1 ]
Roy, Celine [2 ]
Taieb, Audrey [2 ]
Chene, Genevieve [2 ]
Matheron, Sophie [4 ]
Brun-Vezinet, Francoise [1 ]
Descamps, Diane [1 ]
机构
[1] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,PRES Sorbonne Paris Cite,Lab Virol, Paris, France
[2] Bordeaux Segalen Univ, ISPED, INSERM, U897, Bordeaux, France
[3] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,PRES Sorbonne Paris Cite,Lab Pharmacol, Paris, France
[4] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite, Serv Malad Infect & Trop, Paris, France
关键词
IMMUNODEFICIENCY-VIRUS TYPE-2; HIV-2; INFECTED-PATIENTS; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; MUTATIONS; SURVEILLANCE; PREVALENCE; SUSCEPTIBILITY; MULTICENTER; SELECTION;
D O I
10.1097/QAD.0b013e32836207f3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the first transmitted drug resistance survey study in HIV-2-infected patients living in France. The prevalence of transmitted drug resistance was 5.0% (95% confidence interval, 0.1-9.9) with mutations detected only in protease, not in reverse transcriptase. In this series, 10% of patients displayed X4/dual-mixed viruses. These findings classified the rate of transmitted drug resistance in the HIV-2 French Cohort as low prevalence.
引用
收藏
页码:1671 / 1674
页数:4
相关论文
共 50 条
  • [31] Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy
    Moranguinho, Ines
    Borrego, Pedro
    Goncalves, Fatima
    Gomes, Perpetua
    Rocha, Jose
    Barreto, Jorge
    Taveira, Nuno
    AIDS, 2020, 34 (03) : 483 - 486
  • [32] Screening and management of HIV-2-infected individuals in Northern Italy
    Costarelli, Silvia
    Torti, Carlo
    Rodella, Anna
    Baldanti, Fausto
    Paolucci, Stefania
    Lapadula, Giuseppe
    Manca, Nino
    Quiros-Roldan, Eugenia
    Izzo, Ilaria
    Carosi, Giampiero
    AIDS PATIENT CARE AND STDS, 2008, 22 (06) : 489 - 494
  • [33] Transmitted drug resistance in patients with acute/recent HIV infection in Brazil
    Ferreira, Ana Cristina G.
    Coelho, Lara E.
    Grinsztejn, Eduarda
    de Jesus, Carlos S.
    Guimaraes, Monick L.
    Veloso, Valdilea G.
    Grinsztejn, Beatriz
    Cardoso, Sandra W.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2017, 21 (04): : 396 - 401
  • [34] Transmitted HIV drug resistance in treatment-naive Romanian patients
    Temereanca, Aura
    Ene, Luminita
    Mehta, Sanjay
    Manolescu, Loredana
    Duiculescu, Dan
    Ruta, Simona
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (07) : 1139 - 1147
  • [35] Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients
    Storto, Alexandre
    Visseaux, Benoit
    Bertine, Melanie
    Le Hingrat, Quentin
    Collin, Gilles
    Damond, Florence
    Khuong, Marie-Aude
    Blum, Laurent
    Tubiana, Roland
    Karmochkine, Marina
    Cazanave, Charles
    Matheron, Sophie
    Descamps, Diane
    Charpentier, Charlotte
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (05) : 1173 - 1176
  • [36] Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001-2009
    Oette, Mark
    Reuter, Stefan
    Kaiser, Rolf
    Lengauer, Thomas
    Faetkenheuer, Gerd
    Knechten, Heribert
    Hower, Martin
    Pfister, Herbert
    Haeussinger, Dieter
    INTERVIROLOGY, 2012, 55 (02) : 154 - 159
  • [37] Transmitted drug resistance in newly diagnosed and treatment-naive HIV type 1-infected patients in Hungary
    Ay, Eva
    Mueller, Viktor
    Mezei, Maria
    Pocskay, Agnes
    Koroknai, Anita
    Mueller, Dalma
    Gyori, Zoltan
    Marschalko, Marta
    Toth, Bela
    Karpati, Sarolta
    Lakatos, Botond
    Szlavik, Janos
    Takacs, Maria
    Minarovits, Janos
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 124 - 130
  • [38] HIV TRANSMITTED DRUG RESISTANCE IN LIMA, PERU
    Trebelcock, W.
    Lama, J.
    Duerr, A.
    Sanchez, H.
    Cabello, R.
    Reisner, S.
    Mayer, K.
    Ignacio, R. Bender
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 84 - 84
  • [39] Epidemiological aspects of transmitted HIV drug resistance
    Girardi, E
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 : 17 - 20
  • [40] HIV treatment decisions and transmitted drug resistance
    Little, SJ
    Smith, DM
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) : 233 - 235